MindBio Therapeutics (CVE:MBIO) | WebDisclosure

Switch to English

9560	Sociétés
188848	Mots-clés
120587	Articles
100788	Communiqués

Accueil
Sociétés
MindBio Therapeutics

COMMUNIQUÉ DE PRESSE

publié le 20/03/2024 à 09:50, il y a 1 année 9 mois

MindBio Begins Landmark Phase 2B Take-Home Microdosing (MB22001) Clinical Trial in Patients with Major Depressive Disorder
Phase 2B trial begins with MB22001 for Major Depressive Disorder patients. Successful Phase 2A trial showed 53% in remission with 14.1 MADRS score drop. MindBio aims to scale up psychedelic treatment for depression

MB22001 Major Depressive Disorder Phase 2b MindBio Psychedelic Treatment
COMMUNIQUÉ DE PRESSE

publié le 20/03/2024 à 09:50, il y a 1 année 9 mois

MindBio Begins Landmark Phase 2B Take-Home Microdosing (MB22001) Clinical Trial in Patients with Major Depressive Disorder
MindBio Therapeutics Corp. commences Phase 2B clinical trial for MB22001 in Major Depressive Disorder patients, following successful Phase 2A trial with significant results

Psychedelic Medicine MindBio Therapeutics Corp. MB22001 Major Depressive Disorder Clinical Trial
BRÈVE

publiée le 04/03/2024 à 11:05, il y a 1 année 9 mois

MindBio Therapeutics passe à l'essai de phase 2B pour la médecine psychédélique dans le trouble dépressif majeur

MindBio Thérapeutique Trouble Dépressif Majeur Essai Clinique De Phase 2B Médecine Psychédélique Microdosage Du LSD
BRÈVE

publiée le 04/03/2024 à 11:05, il y a 1 année 9 mois

MindBio Therapeutics Advances to Phase 2B Trial for Psychedelic Medicine in Major Depressive Disorder

Psychedelic Medicine Major Depressive Disorder Microdosing LSD Phase 2b Clinical Trial MindBio Therapeutics
COMMUNIQUÉ DE PRESSE

publié le 04/03/2024 à 11:00, il y a 1 année 9 mois

MindBio Therapeutics Receives Final Regulatory Approval to Conduct Phase 2B Randomised Controlled Trial Microdosing Mb22001 in Patients Diagnosed with Major Depressive Disorder
Ethics and regulatory approvals finalized for world-first take-home use of psychedelic medicine MB22001 in Phase 2B randomized controlled trial for Major Depressive Disorder by MindBio Therapeutics Corp

Psychedelic Medicine MB22001 Major Depressive Disorder MindBio Therapeutics Phase 2B Trial
BRÈVE

publiée le 26/02/2024 à 10:30, il y a 1 année 9 mois

MindBio annonce des résultats positifs dans un essai clinique de microdosage à domicile pour la dépression

Depression MB22001 Essai Clinique MindBio Microdosage
BRÈVE

publiée le 26/02/2024 à 10:30, il y a 1 année 9 mois

MindBio Announces Positive Results in At-Home Microdosing Clinical Trial for Depression

Depression MB22001 MindBio Microdosing Clinical Test
COMMUNIQUÉ DE PRESSE

publié le 26/02/2024 à 10:30, il y a 1 année 9 mois

MindBio Therapeutics Announces Positive Depression Data from World-First Phase 2a Take-Home Microdosing Trial
MindBio announces positive top line data from its world-first take-home microdosing depression clinical trial using MB22001. Patients experienced a 60% reduction in depressive symptoms with an impressive mean 14.1 point drop in MADRS score over 8 weeks

Psychedelic Medicine Depression MB22001 Clinical Trial MindBio
COMMUNIQUÉ DE PRESSE

publié le 14/02/2024 à 10:00, il y a 1 année 10 mois

MindBio Therapeutics Completes World First Take Home Phase 2a Microdosing Depression Trial
MindBio Therapeutics Corp. completes landmark Phase 2a clinical trial in Major Depressive Disorder patients with regulatory approvals for take-home use of proprietary microdose LSD MB22001. Phase 2B trial in late-stage cancer patients ongoing. CEO Justin Hanka announces pivotal moment for psychiatric medicine development

MindBio Therapeutics Corp. Major Depressive Disorder Clinical Trial Phase 2a LSD Microdosing
COMMUNIQUÉ DE PRESSE

publié le 30/01/2024 à 08:10, il y a 1 année 10 mois

MindBio Therapeutics Nears Completion of Landmark Phase 2a LSD Microdosing (MB22001) Clinical Trial in Depressed Patients
MindBio Therapeutics Corp. is nearing completion of its Phase 2a clinical trial using MB22001 in patients with Major Depressive Disorder. The company expects top line results to be announced in March 2024. MindBio is conducting trials with regulatory approvals for take-home use of a special form of LSD in microdoses, aiming to treat mental health conditions

MindBio Therapeutics Corp. Phase 2a Clinical Trial MB22001 Major Depressive Disorder Microdosing LSD

Les Echos

Publié le 19/12/2025 à 21:57, il y a 1 jour

Mise à disposition du document d’enregistrement universel
Publié le 19/12/2025 à 08:30, il y a 1 jour 14 heures

Share capital decrease by way of treasury shares cancellation
Publié le 19/12/2025 à 08:30, il y a 1 jour 14 heures

Réduction du capital par voie d’annulation d’actions propres
Publié le 19/12/2025 à 07:00, il y a 1 jour 15 heures

EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS
Publié le 19/12/2025 à 07:00, il y a 1 jour 15 heures

EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 20/12/2025 à 00:30, il y a 22 heures 9 minutes

Alphinat Announces a Profit of $120,155 for Fiscal Year Ended August 31, 2025
Publié le 19/12/2025 à 22:00, il y a 1 jour

GMV Minerals Inc. Closes Non-Brokered Equity Financing
Publié le 19/12/2025 à 18:30, il y a 1 jour 4 heures

Eagle Plains Shareholders Approve all Matters at Annual General Meeting
Publié le 19/12/2025 à 14:40, il y a 1 jour 7 heures

Northern Superior Announces Closing of the Arrangement
Publié le 19/12/2025 à 13:30, il y a 1 jour 9 heures

Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF

Voir tout ACCESSWIRE

EQS Group

Publié le 20/12/2025 à 16:45, il y a 5 heures 53 minutes

Shanghai Electric Powers Up Iraq's Energy Future with Major 625MW Efficiency Upgrade
Publié le 20/12/2025 à 10:05, il y a 12 heures 33 minutes

FITUR 2026 highlights the strong synergies between Germany and Spain
Publié le 19/12/2025 à 22:03, il y a 1 jour

EAMD: Trading resumes on the Düsseldorf Stock Exchange, lawsuit filed by minority shareholders dismissed, capital increase for investments in drone projects in the defense tech sector
Publié le 19/12/2025 à 21:40, il y a 1 jour

IMG Saxony-Anhalt: 2026 in Sight - Saxony-Anhalt Sets the Pace for Future Industries
Publié le 19/12/2025 à 20:35, il y a 1 jour 2 heures

Nobu Manchester breaks ground as Robert De Niro visits Manchester with Salboy